Crowd sourcing in drug discovery

Nature Reviews Drug Discovery

Volumn 10, Issue 4, 2011, Pages 241-242

  Lessl, Monika ^a   Bryans, Justin S ^b   Richards, Duncan ^c   Asadullah, Khusru ^a  

^a BAYER PHARMA AG   (Germany)

^b Centre for Therapeutics Discovery   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; CARDIOLOGY; CROWD SOURCING; DISEASE ASSOCIATION; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; GYNECOLOGY; HEALTH CARE PLANNING; HUMAN; INTERNET; KNOWLEDGE; MEDICAL CARE; MOLECULAR IMAGING; NOTE; ONCOLOGY; ORGANIZATION; OUTCOME ASSESSMENT; PATENT; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; SCHOOL; SOCIAL MARKETING; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; INTERNET; RESEARCH; TRANSLATIONAL RESEARCH;

EID: 79953319797     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3412     Document Type: Note

References (4)

1. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug. Discov. 9, 203-214 (2010).
2. Howe, J. (ed.) Crowdsourcing: Why the Power of the Crowd is Driving the Future of Business. (Crown Publishing Group, New York, 2008).
3. Lessl, M. et al. Grants4Targets - a novel approach to translate basic research to novel drugs. Drug Discov. Today 1 Dec 2010 (doi:10.1016/j.drudis. 2010.11.013).
4. Bishop, M. The total economic impact of InnoCentive's enterprise solution: challenges, InnoCentive@work and ONRAMP. (Forrester Business Consulting, Cambridge, Massachusetts, 2010).